Literature DB >> 17625496

Progress toward interruption of wild poliovirus transmission--worldwide, January 2006-May 2007.

.   

Abstract

Progress toward global polio eradication continued during 2006 and the first 5 months of 2007, although the number of countries where wild poliovirus (WPV) transmission has never been interrupted remained at four (Afghanistan, India, Nigeria, and Pakistan). Continuing challenges included intense WPV circulation in northern India during 2006, low vaccination coverage with oral polio vaccine (OPV) during supplemental immunization activities (SIAs) in Nigeria, and security problems preventing access to children during SIAs along the Afghanistan-Pakistan border. Programmatic strategies to address these challenges consisted of large-scale use of type 1 monovalent oral polio vaccine (mOPV1), targeted programs (e.g., cross-border synchronization of polio campaigns) to reach more children through SIAs, and introduction of new laboratory procedures to confirm cases more rapidly. This report summarizes these strategies and overall progress toward global polio eradication.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17625496

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  7 in total

1.  Shedding of vaccine viruses with increased antigenic and genetic divergence after vaccination of newborns with monovalent type 1 oral poliovirus vaccine.

Authors:  Sabine van der Sanden; Mark A Pallansch; Jan van de Kassteele; Nasr El-Sayed; Roland W Sutter; Marion Koopmans; Harrie van der Avoort
Journal:  J Virol       Date:  2009-06-10       Impact factor: 5.103

Review 2.  Microneedle-based vaccines.

Authors:  Mark R Prausnitz; John A Mikszta; Michel Cormier; Alexander K Andrianov
Journal:  Curr Top Microbiol Immunol       Date:  2009       Impact factor: 4.291

3.  Genetic relationships and epidemiological links between wild type 1 poliovirus isolates in Pakistan and Afghanistan.

Authors:  Mehar Angez; Shahzad Shaukat; Muhammad M Alam; Salmaan Sharif; Adnan Khurshid; Syed Sohail Zahoor Zaidi
Journal:  Virol J       Date:  2012-02-22       Impact factor: 4.099

4.  Cross-border collaboration between China and Myanmar for emergency response to imported vaccine derived poliovirus case.

Authors:  Hai-Bo Wang; Li-Fen Zhang; Wen-Zhou Yu; Ning Wen; Dong-Mei Yan; Jing-Jing Tang; Yong Zhang; Chun-Xiang Fan; Kathleen H Reilly; Wen-Bo Xu; Li Li; Zheng-Rong Ding; Hui-Ming Luo
Journal:  BMC Infect Dis       Date:  2015-01-17       Impact factor: 3.090

5.  Distribution pattern of poliovirus potentially infectious materials in the phase 1b medical laboratories containment in conformity with the global action plan III.

Authors:  Bassey Enya Bassey; Fiona Braka; Faisal Shuaib; Richard Banda; Sisay Gashu Tegegne; Johnson Muluh Ticha; Walla Hamisu Abdullalhi; Olatunji Mathew Kolawole; Yusuf Kabir
Journal:  BMC Public Health       Date:  2018-12-13       Impact factor: 3.295

6.  Lessons Learnt from Interregional and Interagency Collaboration in Polio Outbreak Response in the Horn of Africa.

Authors:  Samuel Okiror; Brigitte Toure; Bob Davis; Rustum Hydarov; Bal Ram; Joseph Okeibunor; Chidiadi Nwogu
Journal:  J Immunol Sci       Date:  2021-04-12

7.  Co-circulation and evolution of polioviruses and species C enteroviruses in a district of Madagascar.

Authors:  Mala Rakoto-Andrianarivelo; Sophie Guillot; Jane Iber; Jean Balanant; Bruno Blondel; Franck Riquet; Javier Martin; Olen Kew; Bakolalao Randriamanalina; Lalatiana Razafinimpiasa; Dominique Rousset; Francis Delpeyroux
Journal:  PLoS Pathog       Date:  2007-12       Impact factor: 6.823

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.